Human Growth Hormone (HGH) Therapy in Boys and Men: Benefits, Risks, and Effects on Fertility and Sexual Health

Introduction

If you or your child has been recommended human growth hormone (HGH) therapy for short stature or other health reasons, you likely have many questions. One common concern is how HGH treatment might affect male fertility, testosterone levels, and sexual development. In this comprehensive guide, we will explain what HGH is and why it is used in children and adults, discuss the potential benefits and risks of therapy, and delve into how HGH use relates to sperm production, future fertility, sexual function, and testosterone. Our goal is to provide clear, evidence-based so that young patients, their families, and adult patients can make informed decisions about HGH therapy.

What is Human Growth Hormone (HGH)?

Human growth hormone (also called somatotropin) is a protein hormone produced by the pituitary gland in the brain. It plays a critical role in normal growth and development during childhood and adolescence, and it helps maintain healthy body structure and metabolism throughout adulthood[1]. In children and teens, HGH stimulates the growth of bones and cartilage, leading to increases in height. After the growth plates fuse in adulthood, HGH continues to support muscle mass, bone density, and the regulation of body fat and blood sugar[2][3].

The body naturally releases HGH in pulses, especially during sleep and exercise, under the control of hormones from the hypothalamus (growth hormone–releasing hormone and somatostatin)[4][5]. If a person’s body does not produce enough growth hormone (a condition called growth hormone deficiency, GHD), it can result in poor growth in children and various health issues in adults, such as low energy, changes in body composition, and reduced bone strength[6][7]. In the mid-20th century, doctors began treating growth hormone deficiency in children with HGH extracted from human pituitary glands. Since 1985, a synthetic recombinant human growth hormone has been available, which is safer and free of the risks that existed with the older pituitary-derived preparations[8]. HGH therapy is given by injection, typically as a daily shot under the skin. Modern delivery devices (pens and injectors) make administration relatively convenient, although it can still be challenging for children and families to cope with frequent injections.

Why is HGH Used? – Indications for Growth Hormone Therapy

HGH is a prescription medication reserved for specific medical indications. Its primary approved use is to treat growth failure in children due to various causes. In adults, it is used as replacement therapy for true hormone deficiency and other select conditions. Below we outline the FDA-approved uses of growth hormone in the United States:

Pediatric Growth Hormone Deficiency (GHD): Children whose pituitary gland does not produce enough growth hormone may be abnormally short and have other symptoms (such as immature facial features or low blood sugar). HGH therapy in these children can restore growth rates to normal or near-normal[8][9]. Treating GHD early helps children attain a height closer to their genetic potential and also improves muscle strength, bone development, and energy levels. In newborn boys, severe congenital GHD can sometimes cause a micropenis (an unusually small penis); treating with HGH in infancy can promote penile growth toward normal size[10][11].
Other Pediatric Growth Disorders: HGH is approved for a number of conditions in children who are very short but do not have a GH deficiency. In these cases, HGH is used to augment height beyond what the child’s body would otherwise achieve. Key examples include:
Turner Syndrome: A genetic condition in girls (missing an X chromosome) that causes short stature and ovarian insufficiency. HGH can increase adult height by an average of a few inches in Turner syndrome[12][13].
Prader–Willi Syndrome (PWS): A genetic disorder causing low muscle tone, obesity risk, and short stature, often with partial GH deficiency. HGH improves growth and body composition in PWS. (It must be used with caution due to risks of breathing issues in these patients.)
Chronic Kidney Disease: Children with chronic renal failure often grow poorly. HGH can help improve growth in pediatric kidney disease.
Small for Gestational Age (SGA): Some babies born very small (SGA) fail to catch up in growth by age 2. HGH is approved to improve growth in those children[14][15].
Idiopathic Short Stature (ISS): This term refers to otherwise healthy children who are extremely short for their age with no identified medical cause. The FDA approved HGH for ISS in 2003 for children below the height of –2.25 SD (essentially the shortest 1.2% for age) and who are unlikely to reach a normal adult height on their own[16]. The response to therapy in ISS is variable – on average, an extra 1.5 to 3 inches of adult height may be gained after several years of treatment[17]. Families must weigh the modest height gain against the burden and cost of years of injections.

Noonan Syndrome, SHOX deficiency, and others: HGH is also approved for short stature associated with Noonan syndrome (a genetic condition with Turner-like features)[18] and for children with a deficiency of the SHOX gene (which can cause short stature). These are less common indications but recognized uses of HGH.
Adult Growth Hormone Deficiency: Adults can have GH deficiency due to pituitary gland tumors, surgery, radiation, or childhood-onset GHD that persists. Adult GHD can cause reduced muscle mass, increased fat (especially around the waist), low energy, poor exercise capacity, and decreased bone density. For adults who clearly meet diagnostic criteria for GH deficiency, HGH replacement can improve body composition (more muscle, less fat), bone strength, and quality of life[19][20]. Many patients report better mood and energy with therapy. It’s important that adult GH deficiency is confirmed by specialized testing; not everyone with nonspecific symptoms is a candidate.
HIV-Associated Wasting: In the 1990s, HGH (Serostim®) was approved to treat muscle wasting and weight loss in patients with advanced HIV infection. It can help increase lean body mass and physical endurance in this setting[21][22]. With modern HIV treatments, severe wasting is less common than it once was, but HGH remains an option in certain cases.
Short Bowel Syndrome: HGH (Zorbtive®) is approved for adults with short bowel syndrome who are dependent on intravenous nutrition. In these patients, HGH can enhance the intestinal absorption of nutrients and fluids[23]. Essentially, it helps the remaining gut work more efficiently to absorb food. This use is relatively specialized and short-term (often a few weeks of therapy along with dietary adjustments).

These are the main on-label uses of HGH in the United States. Importantly, growth hormone is not indicated for simple short stature when the height is within the normal range for the population, nor is it intended as a general tonic for aging or athletic enhancement. We will discuss those scenarios next.

Off-Label and Unapproved Uses of HGH

Because HGH has potent effects on body composition and metabolism, it has attracted attention outside of standard medical practice. Some clinics and online vendors promote HGH for uses such as anti-aging, bodybuilding, athletic performance, or general wellness in older adults. However, it is critical to understand that using growth hormone without a true medical indication is risky and in many cases illegal. In fact, U.S. law explicitly prohibits distribution of HGH for any anti-aging or bodybuilding purposes[24][25]. HGH can legally be prescribed only for the specific conditions approved by the FDA (or under carefully monitored clinical trials). This means prescribing growth hormone to otherwise healthy adults to combat aging or enhance athletic performance is against federal law[24][26].

Why such strict regulation? Decades of research have failed to show that HGH is a “fountain of youth.” While a famous 1990 study suggested that HGH injections in older men led to increased muscle and reduced fat, later studies found no significant improvement in strength or functional abilities, and noted frequent side effects like joint pain and diabetes risk. In fact, excessive HGH might accelerate aspects of aging – for example, high IGF-1 levels (a result of HGH activity) have been linked to increased risk of certain cancers[27][26]. Experts have warned that many claims made by anti-aging clinics are unproven and that long-term HGH use in normal aging could shorten lifespan rather than extend it[27][28].

Similarly, some athletes have abused HGH, often in combination with anabolic steroids, trying to gain muscle and recovery speed. HGH is banned in professional sports and by the World Anti-Doping Agency. Athletes caught using it face sanctions, and the health consequences can be serious (including diabetes, nerve pain, and cardiac issues). It’s worth noting that unlike anabolic steroids, HGH does not directly increase muscle strength beyond normal levels – any muscle mass gained is often accompanied by side effects like fluid retention and carpal tunnel syndrome. In short, there is no safe “boost” from HGH for someone who does not medically need it. The off-label use of HGH is all risk and expense, with little to no legitimate benefit to justify it.

Key Point: If you encounter an anti-aging product or clinic offering HGH (pills, sprays, or injections), be very cautious. Many over-the-counter “HGH supplements” don’t actually contain real HGH (or contain amounts too small to work). Legitimate HGH is a prescription-only peptide that would be digested if taken by mouth (so pills or sprays are ineffective)[29]. Paying hundreds of dollars for these products is essentially “paying for sand and water,” as one expert put it[29]. Always discuss with a qualified physician before considering any hormone therapy.

Benefits of HGH Therapy

When used for the proper medical indications, HGH therapy can provide significant benefits. Let’s break down the potential benefits by patient group:

In Children and Adolescents: The clearest benefit of HGH treatment in kids with growth hormone deficiency or other approved conditions is improved growth and height. Parents often notice an acceleration in their child’s linear growth within 3–6 months of starting therapy. Over a few years, many children “catch up” substantially in height to approach a more average percentile for their age. For example, a child with severe GHD might grow less than 2 inches per year before treatment but 4 or more inches per year during the initial years on HGH. For non-deficient short stature (like idiopathic short stature or Turner syndrome), the growth response is more modest, but many children still achieve a taller adult height than they would have without treatment[17][12]. This can have positive effects on self-esteem and quality of life for some patients, though it’s important to have realistic expectations about final height.

Beyond height, HGH contributes to building a healthier body composition. Children on therapy often develop more lean muscle and stronger bones. If a child had low muscle tone or decreased stamina (for instance, in Prader-Willi syndrome or GHD), HGH can improve their strength and energy for physical activity. Bone density, which can be reduced in GH-deficient patients, gradually improves with treatment, reducing future risk of osteoporosis. There may also be metabolic benefits: HGH helps regulate fat distribution and may improve cholesterol profiles. Additionally, some cognitive or mood benefits have been noted anecdotally in GHD children once therapy begins, likely because they simply feel better physically.

In Adults with GH Deficiency: Adults who truly lack growth hormone can experience a range of symptoms – fatigue, depressed mood, reduced exercise capacity, increased abdominal fat, and low bone density. HGH replacement in these adults aims to restore normal physiology. Clinically, many patients report: better energy and endurance, enhanced exercise tolerance, and improvements in mood and sense of well-being once on a proper dose of HGH. Body composition shifts over several months, with a reduction in visceral (deep belly) fat and an increase in muscle mass[19][30]. Over longer periods, HGH can increase bone mineral density, which is important to prevent fractures. There is also evidence that long-term therapy in adults can improve cholesterol levels (reducing LDL) and modestly lower cardiovascular risk factors when dosed correctly[20]. Quality of life studies have found that adults on GH replacement often score higher on measures of emotional well-being, physical mobility, and vitality compared to their pre-treatment baseline[31][32].

It must be emphasized that these benefits apply to individuals with documented GH deficiency. They derive from bringing a deficient hormone level back to normal. In someone with normal GH production, adding extra HGH is unlikely to make a healthy person “superhuman.” In fact, supra-physiological doses in a normal person might cause adverse effects (as discussed in the risks section). So, the goal of therapy is to normalize growth hormone levels/IGF-1 levels – not to exceed the normal range.

Psychosocial Benefits: For many pediatric patients, a key benefit of successful HGH therapy is improved psychosocial well-being. Children who grow significantly in stature may feel more confident and face less teasing or self-consciousness about their height. This can translate into a more positive school experience and social life. For example, a teenager with idiopathic short stature who gains an extra 2–3 inches after years of feeling abnormally short may report higher self-esteem. It’s important to recognize these benefits, while also helping children develop confidence and coping skills regardless of height. Counseling and support should go hand-in-hand with any medical therapy for short stature.

Risks and Side Effects of HGH Therapy

Any medical treatment that offers benefits may also come with side effects and risks, and HGH is no exception. However, when HGH is used in appropriate patients under medical supervision, it is generally considered safe. Most side effects are dose-dependent and manageable by adjusting the dosage. Below we outline the known side effects and risks, emphasizing which are more common and which are rare:

Common Side Effects:
– Injection Site Reactions: Because HGH is given as a subcutaneous injection, some patients (especially children) experience pain, redness, itchiness, or bruising at the shot site[33]. Rotating injection sites and using proper technique can minimize these issues. – Joint and Muscle Aches: As growth hormone shifts fluid and promotes tissue growth, transient muscle or joint pain can occur, particularly in adults starting therapy[33]. For example, some patients report stiffness in their hands or mild knee pain early on. These aches are usually mild and tend to resolve with dose adjustment or time. Over-the-counter pain relievers can be used if needed, but persistent pain should be discussed with the doctor. – Fluid Retention and Edema:HGH can cause the body to hold onto water. Adults might notice mild swelling in the fingers or ankles, or a sensation of puffiness. This can also contribute to carpal tunnel syndrome (numbness or tingling in the hands) in some cases[34]. Edema and related symptoms are more common in older adults or those on higher doses. Reducing the dose usually alleviates these symptoms. – Headaches: Some patients get headaches when starting HGH. Often these are mild tension-type headaches that improve over time. However, a severe or persistent headache could signal a more serious side effect (see below). – Metabolic Changes: Growth hormone can induce insulin resistance, meaning the body becomes a bit less responsive to insulin. In most patients this doesn’t cause any noticeable symptoms, but in some it can raise blood sugar levels. Rarely, HGH might unmask latent diabetes or slightly increase the risk of developing type 2 diabetes, especially if there are other risk factors[35]. Doctors typically monitor glucose levels during therapy, particularly in patients with other risks for diabetes. A balanced diet and regular exercise can help counteract this effect.

Rare but Important Side Effects:
– Intracranial Hypertension (IH): This is a very uncommon side effect where the pressure of the fluid around the brain temporarily increases. It can cause severe headaches, nausea/vomiting, and visual changes (blurred or double vision). In children, it may present as morning headache or reluctance to lie down. If a patient on HGH complains of bad headaches with these features, medical evaluation is needed right away. IH related to HGH is usually benign and reversible – stopping the therapy for a time and then restarting at a lower dose is a typical approach. This side effect is rare (estimated in roughly 1 out of a few thousand patients), but because it can be serious, patients and families should be aware of the warning signs[36][37]. – Slipped Capital Femoral Epiphysis (SCFE): SCFE is a orthopaedic condition where the growth plate at the hip slips, causing hip pain and limping. It is most often seen in early adolescence, especially in rapid growth phases or in overweight youth. Rapid growth from any cause, including HGH therapy, can slightly increase the risk. It’s still uncommon, but pediatric endocrinologists watch for complaints of hip or knee pain in their patients. If a child on HGH develops a persistent limp or hip/knee pain, they should be promptly evaluated by a doctor[38][39]. Treatment of SCFE usually requires surgical pinning of the hip. Prompt detection is key to prevent lasting joint problems. – Worsening of Scoliosis: Because HGH can speed up growth, children who have scoliosis (curvature of the spine) might experience a progression of the curve during periods of rapid growth. This is not because HGH damages the spine, but simply because the child is growing faster. Scoliosis progression has been noted particularly in conditions like Turner syndrome during HGH treatment[13]. Orthopedic monitoring (regular spine exams) is advised for patients at risk, so that bracing or other interventions can be done if needed. – Pancreatitis: A very rare side effect, but there have been infrequent case reports of pancreatitis (inflammation of the pancreas) in patients on growth hormone. Signs would include severe abdominal pain. This is extremely uncommon and not definitively proven to be caused by HGH in most cases, but it is listed as a potential serious adverse event in prescribing information[40][34]. – Changes in Glucose/Diabetes: As mentioned, while mild insulin resistance is relatively common, a few patients may develop type 2 diabetes while on HGH (especially those with obesity or a family history). Additionally, in patients with diabetes, growth hormone can make blood sugar control more challenging, requiring adjustments in diabetes medications. Doctors will monitor hemoglobin A1c or fasting glucose periodically. For the majority without pre-existing risk, clinically significant diabetes is rare. – Cancer Risk: There has been ongoing discussion about whether long-term HGH therapy could influence cancer risk. Growth hormone increases levels of IGF-1, a hormone that can promote cell proliferation. In theory, this could affect cancer risk or growth of existing tumors. Patients with an active or recent malignancy are generally not candidates for HGH therapy due to concern that it could stimulate tumor recurrence. What about otherwise healthy patients on GH? Large studies have not shown a clear increase in de novo cancer rates among childhood GH recipients in the short to mid-term. Some older studies suggested slight increases in certain cancer risks in GH-treated childhood cancer survivors, but these patients also had prior radiation and other factors[41][42]. Reassuringly, a recent long-term study did not find a significant rise in new cancers among adults who were treated with GH in childhood for isolated growth failure[43]. There is even some evidence that appropriate GH replacement in deficient adults might improve overall health and potentially reduce cancer risk by improving immune function and body composition[44]. Overall, the consensus is that HGH therapy is not linked to any major cancer risk increase when used in approved indications, but out of caution, physicians avoid using HGH in anyone with active cancer and monitor IGF-1 levels to avoid excessive dosing. – Other Rare Effects: These can include allergic reactions (extremely rare, since GH is nearly identical to human natural GH), pressure on the carpal tunnel nerve (causing wrist pain/numbness), or edema in the brain if there is an undiagnosed benign tumor (HGH can sometimes cause existing meningiomas to swell). Such scenarios are very uncommon. Before starting GH, doctors screen for any intracranial tumors (like a pituitary adenoma) that could contraindicate therapy.

In summary, HGH therapy is considered safe when properly prescribed and monitored. Most children and adults tolerate it well. Healthcare providers will schedule regular follow-ups (typically every 3–6 months) to check growth progress, adjust dosage, and ask about any symptoms. They will also do blood tests (like IGF-1 levels) to ensure dosing is in the right range and occasionally other labs like blood sugar or cholesterol. In children, eye exams might be recommended early in therapy to catch rare intracranial pressure issues. By staying vigilant, doctors can catch side effects early and take appropriate action (for example, pausing treatment if needed, then restarting at a lower dose).

It’s very important to never exceed the prescribed dose of HGH and never use it without a prescription. Most of the serious side effects have occurred in situations of overdosage or inappropriate use. With recommended doses tailored to the patient’s age and weight, side effects are usually minimal.

HGH and Puberty/Sexual Development in Males

Many families ask whether growth hormone treatment will affect the timing of puberty or the sexual development of their sons. This is an important question, as hormones can interact in complex ways during adolescence. Here’s what research and clinical experience tell us:

Timing of Puberty: Normal puberty in boys is triggered by the activation of the pituitary gland’s production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which stimulate the testes to produce testosterone and sperm. This process (the HPG axis) is distinct from the growth hormone axis. Growth hormone itself is not the trigger for puberty – for example, some children with isolated GH deficiency will go into puberty at a normal time (because their reproductive hormones are intact), and conversely, children without GH can still undergo puberty (though they may grow less during it). However, growth hormone does play a supporting role in pubertal development. GH and the IGF-1 it produces are thought to modulate the pace of puberty and contribute to achieving full sexual maturation[45]. Research has shown that GH is important for reaching normal gonadal size(testicular size) in males and may have a permissive effect on the timing of puberty[45]. Boys with untreated GH deficiency often have delayed puberty or a slower progression of puberty, even if their gonadotropin (LH/FSH) levels are normal[46][47]. In other words, lack of GH can subtly slow things down.
Micropenis in Infancy: As mentioned earlier, severe congenital GH deficiency in infant boys can result in a micropenis at birth[10]. This highlights that GH has a role (alongside testosterone) in early penile growth. Pediatric endocrinologists are aware of this, and if a newborn boy is found to have a micropenis, one of the evaluations is for GH deficiency (as well as gonadotropin deficiency). Treating an infant with GH deficiency using HGH can lead to significant increase in penile size during the first year of life[48][49]. It’s a dramatic example of how GH and sex development interplay in the body’s hormone network.
Effect of HGH Therapy on Puberty Progression: For most children who start HGH at a young age, HGH does not cause early (precocious) puberty. Large studies and clinical trials have not found HGH therapy to trigger puberty onset in boys who weren’t already entering puberty. The onset of puberty is still governed by the brain’s timing (genetics and other factors). Some children on long-term GH therapy may enter puberty slightly earlier than expected for their condition, but often this is because they catch up in growth to a level where the body is ready for puberty, not because the medication directly started it. In idiopathic short stature, for instance, there is no evidence that HGH causes abnormal early puberty; treated boys generally go into puberty around the same time as their peers (or when they were genetically predisposed to)[50][51]. In fact, HGH-treated boys typically have normal progression through Tanner stages of puberty and normal pubertal increases in testicular volume, as documented by studies following teens who took HGH during puberty[50][51].
Testicular Growth and Development: One of the concerns is whether long-term HGH therapy could shrink or harm the testes. Reassuringly, it does not. This is very different from anabolic steroids or testosterone abuse, which can suppress testicular function and cause testicular shrinkage. HGH works via different pathways and doesn’t replace or suppress the gonadotropins (LH/FSH) needed for testicular growth. In fact, evidence suggests the opposite: GH is needed for full testicular development. Boys with isolated GH deficiency, when given only testosterone during puberty (without GH), reach puberty but may end up with smaller testes than average[45]. When GH is added, testicular growth improves. A medical study compared teenagers with delayed puberty/short stature who had received HGH versus those who hadn’t. It found that those treated with HGH during puberty had normal testicular size and function at the end of puberty, with normal testosterone levels and sperm parameters for their age[50][51]. The study concluded that HGH therapy had no detrimental effect on male gonadal maturation in these individuals[52][51].
Puberty in Conditions Requiring HGH: Some genetic conditions that use HGH have their own effects on puberty. For example, in Turner syndrome (which affects girls), patients often need estrogen replacement to induce puberty, since their ovarian function is low. In Prader-Willi syndrome(boys or girls), puberty can be incomplete due to hypothalamic issues – those patients might need sex hormone replacement as well, irrespective of HGH. Noonan syndrome boys might have delayed puberty, but HGH therapy in those cases doesn’t negatively affect their eventual pubertal development. It’s important to differentiate these underlying issues from HGH itself. HGH will generally allow a boy to progress through puberty in alignment with his body’s signals (and potentially help him achieve better growth during the pubertal growth spurt).

In summary, HGH therapy is not known to interfere with the normal process of puberty in boys. It does not castrate, feminize, or delay pubertal maturation. If anything, ensuring adequate growth hormone levels supports overall healthy development. Parents can be reassured that a boy on HGH for short stature will go through puberty according to his own internal timetable (unless another condition affects it). He will develop normal male secondary sexual characteristics (deepening voice, facial hair, genital development) driven by testosterone, just like any other adolescent. If a boy with GH deficiency also has issues with puberty due to a pituitary problem, the medical team will address that with appropriate treatments (like testosterone shots) when the time is right. HGH itself will complement that process by optimizing growth and physical maturation.

HGH, Sperm Production, and Future Fertility

When considering HGH treatment for a child or teen, families often wonder: “Will this medication affect my son’s ability to have children of his own in the future?” Adult male patients starting HGH might ask similarly, “Could this hormone therapy impact my sperm count or fertility?” These are very important questions. We have accumulating evidence and clinical experience to answer them.

Fertility in Males with Growth Hormone Deficiency

Growth hormone deficiency (GHD), especially if it begins in childhood and is not treated, can have subtle adverse effects on the development of the reproductive system. Remember that the testes (the male reproductive glands) grow and mature mostly under the influence of gonadotropins (LH and FSH) and testosterone during puberty. However, GH and IGF-1 also appear to play a role in achieving full testicular growth and optimal sperm production. Medical observations support this:

Boys with untreated GHD often have smaller testicular volume by the end of puberty than their healthy peers[53][54]. This condition of smaller than normal testes is sometimes called testicular hypotrophy.
Untreated GHD through puberty has been associated with a reduction in sperm output. In a recent controlled study, young men who grew up with GHD (and were not fully treated) had, on average, a lower total sperm count and lower sperm motility compared to age-matched healthy men[55][54]. They also had lower semen volume and were more likely to have oligospermia (low sperm concentration)[55]. It’s important to note that in that study the men with GHD still had normal levels of LH, FSH, and testosterone – their pituitary-gonadal axis was otherwise intact[56]. This means their fertility issues were likely due to the lack of GH/IGF-1 influence during their development, not due to low testosterone or gonadotropins.
The good news is that treating GH deficiency in childhood and adolescence appears to mitigate these issues. Clinical experience shows that boys who receive HGH for GHD go through puberty with normal or near-normal testicular sizes and can achieve normal fertility. HGH therapy essentially “sets the stage” for the testes to develop properly when puberty hormones kick in. In line with this, that same study suggested that having an intact GH-IGF-1 axis in childhood is important for full fertility potential in adulthood[57].

In practice, many men who had childhood GHD and were treated with HGH have gone on to father children, provided they didn’t have other reproductive issues. If the GH deficiency was part of broader pituitary failure that also affected gonadotropins, then fertility would depend on treating those hormones (often with gonadotropin injections to induce sperm production). But isolated GHD, once corrected with therapy, does not seem to impair future fertility. In fact, if GHD is left untreated, there is a risk of subfertility, so treating it is the better path for long-term reproductive health.

Fertility in Males with Normal GH Levels (Idiopathic Short Stature or Other Non-GHD Conditions)

What about boys who are not GH-deficient but take HGH for short stature (ISS or other conditions)? Can the medication itself cause fertility problems down the line? The evidence here is reassuring as well. A follow-up study of young men who had received HGH during puberty for idiopathic short stature or constitutional delay (meaning they were healthy, just late bloomers or very short) found no adverse effect on their reproductive function[50][52]. In that study, once the boys reached young adulthood, they underwent exams and lab tests. All of them had normal testicular size for adults, their hormone levels (testosterone, LH, FSH, inhibin) were in the normal range, and when semen analyses were done, the sperm counts and motility were within normal limits for their age (some were still teenagers, so not all had optimal sperm parameters yet, but nothing out of the ordinary)[50]. Only one individual had some abnormal semen parameters, and that was considered likely unrelated or within the variability seen in late adolescence[58]. The researchers concluded that HGH therapy did not harm the development or maturation of the testes in these patients[52].

This makes sense biologically: giving extra GH to a person who already makes GH won’t shut down the gonads (again, GH is not a gonadotropin or sex steroid that would cause feedback inhibition). At most, it might raise IGF-1 levels higher than typical during treatment, but studies have not shown any negative impact of that on later fertility. In fact, some hypothesize that the higher IGF-1 in those years could even support spermatogenesis (sperm development), though there isn’t direct proof of enhanced fertility beyond normal. The key point is that HGH therapy in an adolescent with normal pituitary function does not seem to impair his ability to have children in the future. Families considering HGH for a short-but-healthy teen can be reassured by these findings. Of course, each individual’s fertility depends on many factors (genetics, any other health issues, exposures, etc.), but HGH itself is not a known cause of infertility in these scenarios.

HGH Therapy in Adult Men and Sperm Production

For adult men receiving HGH (usually for adult-onset GH deficiency), how does it affect sperm? There is evidence that GH plays a role in adult testicular function as well. Men with GH deficiency sometimes have suboptimal sperm characteristics even if their testosterone is adequate, as noted above. When adult men with GH deficiency are treated with HGH, there are a few notable effects: – Leydig Cell Function: Leydig cells in the testes produce testosterone in response to LH. GH seems to enhance the function of these cells. In a study of men with adult GH deficiency, 6–12 months of HGH therapy led to an increased testosterone response when the testes were stimulated (with hCG, a compound similar to LH)[59][60]. In other words, after GH treatment, their testes produced more testosterone for the same stimulus than before. This suggests GH can improve the capacity of Leydig cells, likely by increasing IGF-1 within the testes which supports cell function. Interestingly, baseline (unstimulated) testosterone levels in that study didn’t significantly change, but the reserve capacity did – indicating a healthier testicular function with GH on board[61][62]. – Semen and Sperm Parameters: The same study found that HGH therapy in GH-deficient men significantly increased the volume of semen (ejaculate volume) over 12 months[63][64]. Think of semen volume as partly a reflection of contributions from accessory glands like the seminal vesicles and prostate, which may respond to IGF-1. However, sperm count, motility, and morphology did not significantly change in that particular group of men[65][66]. They were essentially normal to begin with and stayed in the normal range, just with more fluid volume. This indicates that bringing GH levels to normal can optimize some aspects of reproductive function that were subpar due to deficiency (like low semen volume or suboptimal Leydig response), but it might not drastically boost sperm count if it’s already normal. If a GH-deficient man had a reduced sperm count initially, it’s possible GH could help indirectly, but other hormone therapy (like gonadotropins) would be the main driver if his gonadotropins were deficient. – Sperm Quality in Normal Men: In men with normal GH levels, adding more GH (for example, athletes or experimental studies) has not shown a clear consistent benefit on sperm count. A few small trials have been done on men with idiopathic infertility to see if GH could help. For instance, one small study found that GH injections increased the number of motile sperm in some men with idiopathic oligospermia (low count)[67][68]. Another study, however, did not replicate an improvement in count[67][69]. The most consistent finding is that GH might improve sperm motility in men who have issues with sperm movement (asthenospermia)[70][68]. But these studies are very limited, and there is no standard practice of giving GH to infertile men unless they are GH-deficient. The improvements seen were modest and not enough to make HGH a recognized fertility treatment for men at this time[71].

Putting it all together, for an adult man on appropriate HGH therapy (replacement doses), one should not expect a negative impact on fertility. If he has GH deficiency, the treatment is likely to improve aspects of his reproductive health (like energy, libido, and possibly sperm quality) to a more normal state. If he does not have GH deficiency (and somehow takes GH illegally), it’s unlikely to improve his fertility and could even cause other hormone imbalances that indirectly hinder fertility (for instance, if high doses are used, it might cause insulin resistance or other issues that aren’t good for overall health). But there is no evidence that proper HGH therapy will reduce a man’s sperm count or cause infertility. Unlike anabolic steroids or testosterone abuse – which do suppress the testicles and often cause temporary infertility – HGH works through different mechanisms and does not shut down gonadotropin production. Men on long-term HGH should remain capable of fathering children, assuming all other systems are in working order.

One caveat: if an adult male patient requires very high doses of HGH (far above replacement) for some medical reason (which is rare), extremely elevated IGF-1 levels might theoretically have some negative feedback on the hypothalamus or pituitary affecting other hormones, but this is not well-documented. Sticking to prescribed doses avoids this concern.

HGH and Testosterone Production

Testosterone is the primary male sex hormone, crucial for sexual development, muscle mass, bone density, and sperm production. It’s natural to wonder how HGH and testosterone interact, since both are hormones important in males and both may be deficient in certain medical scenarios.

The relationship between growth hormone and testosterone is generally positive and synergistic: – During puberty, the simultaneous rise in GH/IGF-1 and testosterone drives the rapid gains in height and muscle. GH and IGF-1 likely amplify the effects of testosterone on tissues. Likewise, sex steroids (testosterone in males, estrogen in females) can stimulate more GH release – that’s one reason pubertal teens have a surge in GH levels. So the two hormone systems often work hand-in-hand during normal development. – In adulthood, testosterone and GH both contribute to maintaining muscle and bone. There’s evidence that men have a higher sensitivity to GH than women, possibly due to testosterone’s influence on GH signaling[72]. In one study, combining GH and testosterone therapy in GH-deficient men led to greater increases in protein synthesis and muscle mass than either hormone alone[73][74]. This underscores a synergistic effect: GH provides the IGF-1 and metabolic push, while T provides the anabolic and strength boost. For this reason, in older patients who truly have both low GH and low T, replacing both hormones to physiological levels can yield significant improvements in body composition. (Note: This is only done in patients who genuinely need it, not as anti-aging treatment for the healthy.)

More specifically, how does HGH therapy influence testosterone levels? – If the pituitary and testes are normal, HGH therapy does not suppress testosterone. It’s not like taking an anabolic steroid or an opioid (those can reduce pituitary signals and drop testosterone). Men and boys on HGH maintain their normal hypothalamic-pituitary-gonadal function. In fact, as mentioned, GH can enhance the testicular capacity to produce testosterone when stimulated[61][60]. Think of GH as providing a better environment in the testes (via IGF-1) for Leydig cells to do their job. The Carani et al. study demonstrated that after GH therapy, when they gave patients an HCG test (which mimics LH), the testosterone rise was higher than before treatment[59][60]. Interestingly, the baseline testosterone in those patients didn’t jump dramatically (it was near low-normal and stayed in normal range), but their testosterone reserve improved[62][75]. For a patient, this might not be overtly noticeable, but it suggests GH helps the testes work more efficiently. – For adolescent boys on HGH, studies find their puberty-related surge in testosterone occurs as expected, and final testosterone levels are typical for adult men[50]. So HGH neither delays nor enhances the actual peak of testosterone – it simply supports normal development. – In adult men with GH deficiency, some may also have low testosterone as part of panhypopituitarism (multiple pituitary hormone deficiencies). Those men will often require testosterone replacement in addition to GH. Growth hormone alone cannot substitute for testosterone if the body isn’t making any – they are different hormones with different functions. But once both are replaced, the patient often experiences a dramatic restoration in vitality. Many doctors observe that a man feels much better when both low GH and low T are corrected together, versus just one or the other, because of the synergistic effects on metabolism and well-being.

Could HGH ever lower testosterone? There’s no direct mechanism for HGH to suppress the gonad axis. However, chronic illness or overdosing on HGH might indirectly affect other systems (for example, if someone took huge doses leading to insulin resistance or other stress, that could possibly affect sex hormone levels indirectly). In normal therapeutic ranges, there’s no evidence of testosterone dropping. Some patients even report improved libido on GH therapy, which is more closely tied to testosterone – possibly because GH treatment can improve their overall energy and mood, which in turn enhances sexual interest (more on sexual function next).

It’s also worth noting that extremely high levels of IGF-1 (like in acromegaly, where a person’s body produces too much GH due to a tumor) can sometimes be associated with lower testosterone levels or hypogonadism. In acromegaly, about a third to half of men can have low testosterone, often due to the pituitary tumor affecting LH/FSH or co-secretion of prolactin[76][47]. So that’s a disease state – not HGH therapy – but it tells us that an excess of GH/IGF-1 in the body can coincide with gonadal dysfunction. When acromegaly is treated (bringing GH/IGF-1 down to normal), sexual function and testosterone often improve[77]. By parallel, if we keep GH therapy within physiological range, we should be in that sweet spot where GH and testosterone work together beneficially.

Bottom Line: In a patient who needs HGH, giving HGH will not diminish testosterone; it may actually help the testes function optimally. Conversely, in someone with normal GH and T, adding more GH won’t significantly raise testosterone either – the body’s feedback loops for testosterone are controlled mainly by LH from the pituitary, not by GH. So HGH is largely neutral to positive on testosterone function. If you’re an adult male on HGH and you notice symptoms of low testosterone (fatigue, low libido, etc.), it’s likely due to an independent issue with your testosterone or pituitary, not due to the HGH itself – and you should discuss this with your doctor, as you might need testosterone evaluation. Many adult GH-deficient patients require a full pituitary hormone work-up anyway, and endocrinologists will ensure other hormones like cortisol, thyroid, and sex hormones are in order while treating with GH.

HGH and Sexual Function

Sexual function in men (and women) can be influenced by many factors – hormones (like testosterone or estrogen), psychological factors, cardiovascular health, nerve function, etc. Growth hormone is not traditionally classified as a “sex hormone,” but it does have some role in sexual health, both directly and indirectly. Let’s break down a few aspects: libido (sexual desire), erectile function, and overall sexual well-being in relation to growth hormone levels.

Libido (Sex Drive): The primary hormonal driver of libido in men is testosterone. However, GH deficiency often comes with symptoms of low energy and depressive mood, which can reduce sex drive. Many adults with GH deficiency report decreased interest in sex and a reduction in overall quality of life[78][76]. When these individuals are treated with HGH, as their vitality and mood improve, it’s common for libido to improve as well. One study noted that men (and women) with either GH deficiency or excess (acromegaly) often experience lowered sexual desire, but when GH/IGF-1 levels are returned to normal (either by giving GH in deficiency or treating the acromegaly), sexual desire tends to rebound alongside other health improvements[46][79]. That suggests a connection – albeit indirect – between balanced GH levels and normal sex drive. In short, treating GH deficiency can help restore a normal libido in those who had lost it, mostly by improving energy levels and mood. For men with normal GH levels, adding extra GH doesn’t appear to further boost libido; normal is normal. Some anti-aging proponents have claimed HGH increases sex drive in older adults, but any such effect is likely placebo or due to improved self-perception from body changes. There isn’t strong scientific evidence that HGH is an aphrodisiac.
Erectile Function: Achieving and maintaining an erection is a complex process involving blood vessels, nerves, and psychological state. The main chemical mediator is nitric oxide, influenced by testosterone and vascular health. GH deficiency can contribute to erectile dysfunction (ED) indirectly. Men with GHD often have fatigue and maybe some endothelial dysfunction (since GH helps maintain blood vessel health). They may also have concomitant deficiencies (like sometimes low testosterone or other pituitary hormones) that cause ED. Some GH-deficient men do report mild ED or less satisfying erections[76]. When treated with HGH, improvements have been observed in some cases. A clinical trial assessing general quality of life in GH-deficient adults found that measures of sexual function improved over the course of therapy, implying better erectile function and satisfaction[80][81]. We must note, though, that if a man’s ED is primarily due to low testosterone or another condition (like diabetes or vascular disease), HGH won’t magically fix that. It’s not a replacement for standard ED treatments or testosterone therapy if needed. However, in the context of GH deficiency, HGH therapy can modestly improve erectile function, likely by enhancing overall blood flow (via IGF-1 effects on blood vessels) and stamina. There is also some research suggesting GH might have a direct effect on the nitric oxide pathway in penile tissue, but this is not fully confirmed.
Sexual Function and Satisfaction: Beyond the mechanics of libido and erection, “sexual function” includes frequency of sexual activity, ability to orgasm, and overall satisfaction. These can be affected by mood and energy. GH-deficient individuals often have a reduced sense of well-being and sometimes depression or anxiety, which can decrease sexual activity frequency and satisfaction. By improving mood and energy, HGH therapy frequently leads to a better sense of self and potentially more engagement in sexual life. Patients commonly report “feeling younger” or “more virile” after months on GH – which might translate into a more active sex life, though again this is usually because their underlying deficiency symptoms are relieved. One scientific review noted that patients with normalized GH levels (from either treating deficiency or acromegaly) had improvements in sexual desire and arousal in both men and women[46][79]. Men with acromegaly, once treated, often saw an improvement in erectile function as well, reinforcing that balanced GH is ideal for sexual health[76][79].
HGH and Female Sexual Function: While our focus is on males, it’s interesting that women with GH issues also report sexual changes – decreased lubrication and pleasure – which sometimes improve with GH therapy or treatment of acromegaly[82][47]. This indicates GH might influence genital blood flow or sensitivity in both sexes to some degree.

One thing to clarify: HGH is not a primary treatment for sexual dysfunction. If a man has ED, the first steps are evaluating testosterone levels, cardiovascular health, etc. If he has GH deficiency, treating it might help, but we wouldn’t give GH to treat ED in someone who isn’t GH deficient. For example, an older man with normal GH but ED will likely benefit more from standard ED medications (like PDE5 inhibitors such as sildenafil) or testosterone therapy if he’s hypogonadal, rather than GH.

That said, for patients who are indicated for HGH therapy, an added perk can be improved sexual well-being. They often feel more confident and physically capable, which can reduce performance anxiety and improve overall satisfaction. Improved body composition (more muscle, less fat) might also increase one’s positive self-image, indirectly benefiting sexual relationships.

In the context of off-label use, some anti-aging clinics tout HGH as a way to enhance sexual performance. As mentioned, there isn’t solid evidence to support this in a person with normal GH levels. Any benefit is likely indirect or psychological. Relying on HGH for sexual enhancement is not recommended and could expose the person to unnecessary side effects.

Diagnosis and Eligibility: How Do We Know Who Needs HGH?

To determine if someone (child or adult) genuinely needs growth hormone therapy, doctors follow a thorough diagnostic process. This is important not only for proper treatment but also because insurance companies typically require proof of medical necessity (due to the high cost of the drug). Here’s an overview of how GHD and other indications are diagnosed:

Assessment of Growth in Children: Pediatric endocrinologists first evaluate a child’s growth pattern. A child who is significantly shorter than peers or whose growth rate has markedly slowed may raise concern for GHD or another growth disorder. The doctor will review growth charts (height and weight over time) and calculate the child’s height percentile. If a child’s height is far below the normal range for age (for example below the 1st or 3rd percentile) or if they have fallen off their percentile curve (e.g., dropping from the 50th percentile at age 2 to the 5th percentile at age 6), further evaluation is warranted[83][84]. The doctor will also look for physical clues of hormone deficiencies (like micropenis in infancy for GH, or midline defects like cleft palate, which can be associated with pituitary problems[85]). A full medical history (including perinatal issues, brain injury, radiation exposure, etc.) is taken. Often they will measure levels of other pituitary hormones and do tests like bone age X-ray (an X-ray of the hand that can show if bones are maturing slowly, which often correlates with delayed growth). If initial screening (like a low IGF-1 level – IGF-1 is usually low in GH deficiency) suggests possible GHD, the gold standard test is a growth hormone stimulation test[86][87]. This involves giving the child a medicine that provokes the pituitary to release GH (common agents are clonidine, arginine, glucagon, or insulin given under careful monitoring) and then measuring GH levels in the blood over a few hours. If the peak GH level stays below a certain cutoff (often ~10 ng/mL, though criteria can vary), it confirms GH deficiency. These tests are done in a controlled setting because some stimulants can cause side effects (e.g., insulin-induced hypoglycemia to test GH). Failing two different stimulation tests is usually required for a definitive GHD diagnosis. Additionally, an MRI of the brain/pituitary might be done to look for any structural cause (like a pituitary malformation or tumor). Once GHD is confirmed, the child qualifies for HGH therapy from a diagnostic standpoint.
Other Pediatric Diagnoses: If GH levels are normal but another condition is suspected (say Turner syndrome in a short girl), the diagnosis is made via specific tests (karyotype for Turner, genetic tests for others). Each of the FDA-approved indications has criteria. For example, idiopathic short stature (ISS) is largely a diagnosis of exclusion – doctors ensure there’s no GH deficiency, no chronic illness, no other syndrome, and that the child’s predicted adult height is very short (often <5’3” for a boy or <4’11” for a girl, or below 2.25 SD from mean)[88][89]. Only then would ISS be considered. In ISS, GH stimulation tests are normal, but the child is still significantly short; insurance might require documentation of height < –2.25 SD and poor growth velocity for approval. For SGA, the child must be proven to have been born small (below certain weight/length percentiles) and still be very short by age 2 or later[14]. For chronic kidney disease, it’s typically short stature in a child with renal failure, often needing a letter from the nephrologist. Each condition (Turner, PWS, etc.) has its own set of diagnostic criteria that the healthcare provider must document for coverage.
Adult GH Deficiency Diagnosis: In adults, diagnosing GH deficiency can be tricky because many healthy adults naturally have lower GH levels as they age. Generally, adults who had childhood GHD should be re-tested after reaching adulthood, because some may regain GH secretion and not need further treatment. For a new adult-onset case, there is usually a clear cause (like a pituitary tumor or surgery). Adult GH deficiency is typically defined as having low IGF-1 levels and failing a GH stimulation test (using e.g. the glucagon stimulation test or insulin tolerance test) under strict criteria. Often, if an adult has multiple other pituitary hormone deficiencies, that alone can strongly suggest GH deficiency, but confirmation tests are still done. Endocrinologists follow consensus guidelines to make sure the diagnosis is accurate, given the cost and commitment of therapy[25].
Who Does Not Qualify: It’s worth noting that normal variants like familial short stature (short parents with short child but normal growth rate) or constitutional delay (late bloomers who are small but will catch up after late puberty) are not conditions where GH is typically indicated (except perhaps in extreme cases overlapping with ISS criteria). Insurance companies require evidence of one of the approved diagnoses. They often demand documentation such as height SD scores, growth velocities, bone age readings, stimulation test results, etc., before authorizing HGH. Off-label requests (like “my 13-year-old is 5’2” and wants to be taller but has no deficiency”) are usually denied coverage, and rightly so from a medical necessity perspective.

For families navigating this process, it can be complex. Pediatric endocrinology teams usually help by handling the insurance approvals, providing the required documentation, and appealing denials if the child truly meets criteria. Patience is key, because sometimes proving GH deficiency requires going through two stimulation tests and waiting for insurance green-lights, which can take time.

Treatment Logistics: Administration and Monitoring

HGH therapy is typically administered as a daily subcutaneous injection (just under the skin). In children, parents or caregivers usually give the shot once a day, often in the evening (to mimic the natural night-time rise of GH). The needles are very small (similar to insulin needles), and many kids adapt to the routine with support and encouragement. Newer formulations of HGH have come out that are long-acting, allowing for once-weekly injections (e.g., lonapegsomatropin, brand name Skytrofa®, or somapacitan). As of 2023, a weekly product (Ngenla™) was approved for pediatric GHD[90]. These long-acting versions can be more convenient (52 shots a year instead of 365). However, they are still very expensive and not yet widely covered by all insurance plans, and the safety data is mostly similar with possibly slightly higher risk of high IGF-1 if not dosed carefully. Many endocrinologists and families are excited about the potential for weekly shots if it means better compliance. As one doctor noted, the best treatment is the one the patient will actually take – and missing fewer doses leads to better outcomes[91][92]. For now, daily HGH remains the standard of care, with weekly options gradually becoming available for some patients.

Patients on HGH will have periodic follow-ups. Children are seen every few months to measure height/weight and adjust dose as they grow. Blood tests for IGF-1 levels are done to ensure the dose is neither too low (IGF-1 below the normal range suggests under-treatment) nor too high (IGF-1 above the age-adjusted normal might suggest overtreatment, which could increase side effect risks). The goal is usually to keep IGF-1 within the normal range for age, or sometimes in the upper part of normal if aiming for maximum growth without exceeding safe levels. Other lab monitoring might include blood sugar tests annually, thyroid function (GH can unmask mild hypothyroidism, so thyroid hormone levels are checked and thyroid hormone replaced if needed), and in adults, lipid profiles and bone density scans after a couple of years.

Costs and Insurance Coverage

One cannot discuss HGH therapy without addressing the cost, as it is famously one of the most expensive chronic medications. In the United States, the cost of recombinant growth hormone can range widely but is typically in the tens of thousands of dollars per year. The exact cost depends on the brand of HGH, the dose (which is usually weight-based or surface-area-based for kids), and the pharmacy or distribution channel. As of mid-2020s data:

For a prepubertal child, a typical dose might cost around $20,000–$40,000 per year[93][94]. For example, a 30-kg child’s treatment was estimated around $20k per year in one analysis[93]. If the dose increases as the child grows, the cost rises accordingly.
A pediatric endocrinologist, Dr. Rohan Henry, noted that daily HGH injections generally run about $25,000 to $35,000 per year, while the newer weekly injections can cost $50,000 or more per year[95][96]. This is consistent with other sources. Essentially, convenience comes at a high price: the long-acting formulations are roughly double the cost at present[95].
Adult doses of GH are usually lower (because we aim just to replace to normal levels, not to stimulate growth), so adult therapy might be somewhat less costly per year than for a growing child. Nevertheless, it is often in the $10,000–$20,000 per year range for adults, depending on dose and formulation[97].

Given these staggering costs, insurance coverage is critical for most families and patients. Health insurance in the U.S. will usually cover HGH for approved indications, but the approval process can be strict. Insurers often require prior authorization with extensive documentation. They may have their own guidelines (often aligned with national guidelines) for what constitutes GH deficiency or ISS, etc., and the prescriber has to submit growth charts, lab results, stimulation test reports, etc. Sometimes an insurance company might initially deny a case like ISS, and then an appeal with a letter of medical necessity is needed. The process can be frustrating, but it’s understandable from a cost perspective. Once approved, patients typically receive the medication through a specialty pharmacy. Some pharmaceutical companies also have patient support programs that provide training on injections, send nurses to help teach injection technique, and even offer co-pay assistance or free drug for uninsured/underinsured patients on a case-by-case basis.

For families without insurance or for off-label uses (which insurance won’t cover), the out-of-pocket cost is usually prohibitive. Paying $2,000–$5,000 per month out-of-pocket is out of reach for most people[98][99]. There are rare instances of wealthy individuals procuring GH for off-label personal use, but that is not the norm. It’s also worth warning that buying HGH from unregulated sources (like some anti-aging clinics or online suppliers) can be dangerous – counterfeit HGH products exist, and without insurance or a legitimate pharmacy, you might receive something that isn’t actually growth hormone or is impure.

From a broader perspective, some countries with national healthcare systems have more stringent criteria for HGH to contain costs. For example, in the UK, the NHS will typically cover pediatric GH therapy for GHD, Turner, PWS, SGA, and chronic renal failure, but not for idiopathic short stature (since that is not universally covered in Europe). This can lead to differences in usage rates internationally. In some European countries, idiopathic short stature treatment is rare due to cost-benefit assessments by health authorities, whereas in the US it’s more common because if insurance approves, families often proceed with it. The ethical debate about treating ISS revolves partly around cost and the psychosocial benefit of a few extra inches of height.

Covered Indications and Diagnosis Confirmation: As mentioned in the diagnosis section, documenting the indication clearly is how one gets coverage. For instance, if the indication is “growth failure due to Turner syndrome,” the endocrinologist will submit the karyotype lab result confirming Turner syndrome, the growth charts showing short stature, etc. If it’s adult GHD, often insurers require not only a stimulation test result but also proof that other pituitary hormone deficits are present or a history of pituitary structural disease – because idiopathic adult-onset isolated GHD is exceedingly rare (so they want to ensure it’s not a false positive test).

Duration of Therapy: Pediatric patients generally continue HGH until they reach their final adult height (or near it). Final height is usually when growth plates close (epiphyseal fusion), which can be confirmed by an X-ray. For GHD children, many will need to resume GH therapy in adulthood if they remain deficient (for health maintenance, not for height). For those on GH for non-deficient shortness, therapy ends when height gains taper off or if they’ve achieved a satisfactory height or reached an age where growth stops. Adults on GH typically use it indefinitely if the deficiency is permanent, but the dose is much lower after the growth years are over. Some childhood-onset GHD patients take a “trial off” GH after reaching adult height to see if they truly need to continue; some will feel fine and not restart, whereas others feel symptoms of deficiency and resume on an adult replacement dose.

Financial Assistance: It’s worth mentioning that many growth hormone manufacturers have assistance programs. These can include co-pay cards that limit out-of-pocket costs for those with commercial insurance, or even free medication programs for families with lower income who don’t have insurance (or have insurance denials) – especially for diagnoses like GHD or Turner where treatment is clearly beneficial. The specifics change year to year, but families can ask their endocrinology clinic’s social worker or the drug company’s support hotline about such options.

Conclusion

Human Growth Hormone therapy can be a transformative treatment for the right candidates – helping a child of short stature grow taller and healthier, or improving vitality and body composition in an adult with deficiency. When considering HGH in boys and men, it’s natural to focus on how it might impact areas of life beyond just height: future fertility, sexual development, and hormonal balance. The evidence, as we’ve explored, is largely reassuring:

HGH therapy does not impair fertility. In fact, for those with GH deficiency, it likely preserves or improves their fertility potential by allowing normal pubertal development and supporting testicular function. Young men treated with HGH in childhood have gone on to have normal sperm counts and the ability to father children[50][52]. HGH does not suppress the reproductive axis like some other hormones can.
HGH therapy does not disrupt normal sexual maturation. Boys on HGH will go through puberty according to their body’s schedule, and HGH will assist in healthy development (for example, preventing issues like micropenis in GH-deficient cases and allowing a robust pubertal growth spurt). It neither causes early puberty nor stunts it.
HGH therapy can have positive effects on quality of life, including sexual well-being for those with GH deficiency. It can increase energy, improve mood, and indirectly benefit libido and sexual function. It is not a primary treatment for sexual dysfunction, but as part of restoring overall health, it plays a supporting role.
HGH must be used responsibly. All the benefits come when the drug is used for legitimate medical reasons under proper supervision. Using HGH as a shortcut for athletic performance or anti-aging is not supported by science and carries avoidable risks. It is also illegal to use or distribute HGH for those purposes in the US[24]. We urge readers to be cautious of any “too good to be true” claims regarding HGH in non-medical contexts.
Costs and practicality are significant considerations. Families and patients should work closely with healthcare providers to navigate insurance and ensure that if treatment is pursued, it’s financially and logistically feasible. The commitment to daily injections (or weekly with newer meds) can be challenging, but many families find creative ways to make it part of the routine (reward charts for kids, numbing cream for injection sites, etc.). Support networks, such as online groups for parents of kids on GH, can provide tips and morale boosts.

Ultimately, the decision to start HGH therapy should involve a thoughtful discussion between the patient (and family) and the endocrinologist. They will weigh the potential benefits (increased height, improved metabolic health, etc.) against the burdens (injections, monitoring, cost, potential side effects). It’s a very individual decision – for some, the benefits are life-changing; for others, the modest gain might not be worth the hassle. And that’s okay. A good medical team will respect the values and preferences of the patient and family.

For those who do proceed, you now have a comprehensive understanding that HGH, when used appropriately, is a friend and not a foe to male development and fertility. Your endocrinologist will monitor growth and health parameters closely to keep treatment safe. Don’t hesitate to ask questions at your visits, and report any side effects or worries. With the partnership of a knowledgeable medical team, patients can achieve the best outcomes – growing and thriving in stature, and stepping confidently into a healthy, fertile adulthood.

Remember, every patient is more than a statistic – whether a boy who wants to catch up to his classmates, or an adult who wants his vigor back. HGH is one tool among many in medicine to help individuals reach their full potential. Used wisely, it can make a significant positive difference while preserving all the things that truly matter – including the ability to have a family in the future and a fulfilling life.

Disclaimer:

The information provided in this blog article is intended solely for general informational and educational purposes and reflects professional opinions, interpretations, and experience. It is not a substitute for personalized medical evaluation, advice, diagnosis, or treatment by a qualified healthcare provider. Reliance on the content of this blog is at your own risk, and nothing contained herein constitutes medical advice, establishes a physician-patient relationship, or is meant to replace consultation with a licensed clinician. Individual circumstances vary, and treatments or diagnostic approaches discussed here may not be appropriate for every person. Always consult your own urologist or other qualified healthcare professional regarding any specific medical condition or treatment decisions. Do not disregard or delay seeking medical advice because of something you read here. If you are experiencing a medical emergency, call 911 or your local emergency number immediately. Efforts are made to ensure accuracy and currency of information; however, medical knowledge evolves rapidly, and content may become outdated, incomplete, or subject to differing clinical opinions. The author and publisher expressly disclaim any responsibility or liability for any loss or harm resulting from reliance on the information contained in this article.

References:

Danowitz M, Grimberg A. Clinical Indications for Growth Hormone Therapy. Adv Pediatr. 2022;69(1):203-217. (Discusses FDA-approved uses of HGH in children, including GH deficiency and other conditions, and notes that recombinant HGH has been used since 1985.)
Cleveland Clinic. Growth Hormone Deficiency (GHD): Symptoms & Treatment. Cleveland Clinic Health Library. Updated 2022. (Provides an overview of GH deficiency, including symptoms like micropenis in male infants and incidence of about 1 in 4,000 to 10,000.)
Radicioni AF, et al. Testicular function in boys previously treated with recombinant human growth hormone for non-growth hormone-deficient short stature. J Endocrinol Invest. 2007;30(11):931-6. (Found that adolescent boys who received HGH for idiopathic short stature had normal adult testicular size, normal hormone levels, and near-normal semen parameters, indicating no adverse effect on gonadal maturation.)
Cannarella R, et al. Testicular function in postpubertal patients with growth hormone deficiency: a prospective controlled study. J Clin Transl Endocrinol. 2025;39:100383. (Reported that young men with untreated childhood-onset GHD had smaller testicular volume, lower semen volume, and lower total sperm count and motility compared to controls, emphasizing the importance of GH for normal testicular development and spermatogenesis.)
Carani C, et al. The effect of chronic treatment with GH on gonadal function in men with isolated GH deficiency. Eur J Endocrinol. 1999;140(3):224-230. (Demonstrated that 12 months of GH therapy in adult GH-deficient men increased IGF-1 levels and hCG-stimulated testosterone levels, and significantly increased seminal fluid volume, without changing sperm count or motility. Concluded GH has a direct effect on Leydig cell function and accessory glands.)
Galdiero M, et al. Growth hormone, prolactin, and sexuality. J Endocrinol Invest. 2012;35(8):782-794. (A review of GH and prolactin in sexual function. It notes that both GH deficiency and GH excess (acromegaly) are associated with decreased sexual desire and erectile dysfunction in men, and that restoring normal GH levels is associated with improvement of sexual function, although effects may be partly indirect or due to concurrent hypogonadism in those conditions.)
Khourdaji I, et al. Frontiers in hormone therapy for male infertility. Transl Androl Urol. 2018;7(3): 347-355. (Summarizes the role of various hormones in male fertility. States that GH is important for timing of puberty and achieving normal gonadal size. Reviews small studies on GH therapy in idiopathic male infertility, noting that GH treatment improved sperm motility in some cases but did not consistently increase sperm counts, so there is insufficient evidence to recommend GH for treating infertility except in GH-deficient men.)
Perls TT, et al. Provision or distribution of growth hormone for “antiaging”: Clinical and legal issues.JAMA. 2005;294(2):2086-2090. (This article, summarized by a University of Illinois at Chicago press release, highlights that off-label distribution of HGH for anti-aging or athletic enhancement is illegal in the U.S. It explains that HGH can only be prescribed for FDA-approved indications – pediatric growth failure, adult GH deficiency, and HIV wasting – and warns that using HGH for anti-aging has no proven benefit and potential serious risks, including diabetes and possible cancer promotion.)
HealthCentral (Laurel Leicht, reviewed by Rabab Jafri, MD). Understanding Pediatric Growth Hormone Deficiency Treatment Options. August 18, 2023. (Provides patient-friendly information on GH treatment in children. Notes that daily GH injections cost approximately $25,000–$35,000 per year and new weekly injections about $55,000 per year, and that insurance usually helps cover these costs. It also mentions possible side effects such as type 2 diabetes risk and intracranial hypertension causing headaches, emphasizing they are rare and usually manageable if caught early.)
MedlinePlus Drug Information: Somatropin Injection. U.S. National Library of Medicine, Last Revised 07/15/2025. (Official patient medication guide for HGH. Lists FDA-approved uses: treatment of growth failure in children (various causes), HIV-related wasting, and short bowel syndrome in adults. Describes common side effects like injection site reactions, joint pain, and rarer serious effects such as vision changes with headache (sign of intracranial hypertension), edema, hip/knee pain (possible SCFE), and a precaution that somatropin may increase the risk of certain cancers. This source supports many of the points on indications, side effects, and safety monitoring.)

[1] [2] [3] [4] [5] HGH (Human Growth Hormone): What It Is, Benefits & Side Effects

https://my.clevelandclinic.org/health/articles/23309-human-growth-hormone-hgh

[6] [7] [11] [86] [87] Growth Hormone Deficiency (GHD): Symptoms & Treatment

https://my.clevelandclinic.org/health/diseases/23343-growth-hormone-deficiency-ghd

[8] [9] [10] [12] [13] [14] [15] [16] [17] [85] [88] [89] Clinical Indications for Growth Hormone Therapy – PMC

https://pmc.ncbi.nlm.nih.gov/articles/PMC9754707

[18] Effect of Growth Hormone Therapy in Patients with Noonan Syndrome

https://pmc.ncbi.nlm.nih.gov/articles/PMC7887459

[19] [31] Ten-Year Change in Quality of Life in Adults on Growth Hormone …

https://academic.oup.com/jcem/article/99/12/4581/2834359

[20] The physiology of growth hormone (GH) in adults

https://joe.bioscientifica.com/view/journals/joe/257/2/JOE-22-0197.xml

[21] [22] [23] [33] [34] [37] [38] [39] [40] Somatropin Injection: MedlinePlus Drug Information

https://medlineplus.gov/druginfo/meds/a622022.html

[24] [25] [26] [27] [28] [29] Growth Hormone Illegal For Off-label Anti-aging Use, Study Warns | ScienceDaily

https://www.sciencedaily.com/releases/2005/11/051108084527.htm

[30] Growth hormone and aging: a clinical review – Frontiers

https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2025.1549453/full

[32] Growth hormone therapy and quality of life in adults and children

https://pubmed.ncbi.nlm.nih.gov/15217307

[35] [36] [83] [84] [91] [92] [94] [95] [96] Treatment for Growth Hormone Deficiency

https://www.healthcentral.com/slideshow/understanding-pediatric-growth-hormone-deficiency-treatment-options

[41] Growth hormone treatment and risk of malignancy – PubMed Central

https://pmc.ncbi.nlm.nih.gov/articles/PMC4357770

[42] [43] Long-term risk of neoplastic events after childhood growth hormone …

https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1360139/full

[44] Growth hormone replacement therapy reduces risk of cancer in adult …

https://www.oncotarget.com/article/13251/text

[45] [67] [68] [69] [70] [71] Frontiers in hormone therapy for male infertility – Khourdaji – Translational Andrology and Urology

https://tau.amegroups.org/article/view/19195/html

[46] [47] [76] [77] [79] [82] Growth hormone, prolactin, and sexuality – PubMed

https://pubmed.ncbi.nlm.nih.gov/23014134

[48] [49] Micropenis secondary to growth hormone deficiency – PubMed

https://pubmed.ncbi.nlm.nih.gov/8648808

[50] [51] [52] [58] Testicular function in boys previously treated with recombinant-human growth hormone for non-growth hormone-deficient short stature – PubMed

https://pubmed.ncbi.nlm.nih.gov/18250614

[53] [54] [55] [56] [57] Testicular function in postpubertal patients with growth hormone deficiency: A prospective controlled study – PubMed

https://pubmed.ncbi.nlm.nih.gov/39897110

[59] [60] [61] [62] [63] [64] [65] [66] [75] The effect of chronic treatment with GH on gonadal function in men with isolated GH deficiency – PubMed